Differential roles of SS18–SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growth
- 11 February 2008
- journal article
- research article
- Published by Elsevier
- Vol. 368 (3) , 793-800
- https://doi.org/10.1016/j.bbrc.2008.01.162
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Expression and Growth Dependency of the Insulin-Like Growth Factor I Receptor in Craniopharyngioma Cells: A Novel Therapeutic ApproachClinical Cancer Research, 2005
- Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptorProceedings of the National Academy of Sciences, 2003
- The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machineryOncogene, 2002
- Role of the Insulin-Like Growth Factor Family in Cancer Development and ProgressionJNCI Journal of the National Cancer Institute, 2000
- Association of SYT-SSX Fusion Types with Proliferative Activity and Prognosis in Synovial SarcomaLaboratory Investigation, 2000
- A Novel Fusion Gene, SYT-SSX4, in Synovial SarcomaJNCI Journal of the National Cancer Institute, 1999
- Expression of insulin-like growth factor receptor, IGF-1, and IGF-2 in primary and metastatic osteosarcomaJournal of Surgical Oncology, 1998
- Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2, in t(X; 18)(p11.2;q11.2)-positive synoviaol sarcomasHuman Molecular Genetics, 1995
- Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcomaNature Genetics, 1994
- Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.Genes & Development, 1993